Fiblast: Began a 30-patient Phase I/II U.S. trial

Scios Nova Inc. (SCIO), Mountain View, Calif. Product: Fiblast, basic fibroblast growth factor (bFGF) Indication: Stroke Status: Began a 30-patient Phase I/II U.S. trial of Fiblast bFGF in stroke. T...